Pharma body wants all excisable goods used for R&D purposes should be exempted from central excise duty. The pharmaceutical industry has asked the government to bring in more clarity in terms of tax structure and provide incentives on research and development (R&D) as part of its budget wish-list. The industry players also want the government to provide a road map towards bringing down corporate income tax down to 25 per cent. The Indian Drug Manufacturers Association (IDMA), a body ... Rediff.com, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!